期刊文献+

镇静催眠作用药物对失眠患者睡眠结构的影响 被引量:27

原文传递
导出
摘要 失眠是一种常见的生理心理疾患,根据2002年全球失眠调查显示,43.4%的中国人在过去1年中经历过不同程度的失眠,其中约20.0%的人选择了使用具有镇静催眠作用的药物解决失眠问题。正常的睡眠结构是保证实现睡眠生理功能的重要条件,而失眠患者往往伴随着睡眠结构的改变。理想的镇静催眠药物不仅能够改善患者的主观睡眠体验,而且能够改善客观睡眠质量,特别是对于睡眠结构应具有正性调节作用。我们总结分析各类具有镇静催眠作用的药物对失眠患者睡眠结构的正性或负性影响,以期对这些药物的合理应用及深入研究提供帮助。
出处 《中华神经科杂志》 CAS CSCD 北大核心 2010年第1期69-71,共3页 Chinese Journal of Neurology
基金 上海市科技发展基金资助项目(08411950700) 全军医学科学技术研究“十一五”计划保健专项课题资助项目(07BJZ06) 第二军医大学长征医院“十一五”“三重三优”学科人才建设计划基金资助项目(2005312)
  • 相关文献

参考文献23

  • 1Feinberg I, Maloney T, Campbell IG. Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications. J Psychiatr Res, 2000, 34: 423-438.
  • 2Drover DR. Comparative pharmaeokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone. Clin Pharmacokinet, 2004, 43: 227-238.
  • 3Perlis ML, McCall WV, Krystal AD, et al. Long-term, non- nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry, 2004, 65:1128-1137.
  • 4Staner L, Eriksson M, Comette F, et al. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study. Sleep Med, 2009, 10: 616-620.
  • 5Terzano MG, Rossi M, Palomba V, et al. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf, 2003, 26: 261-282.
  • 6Staner L, Ertle S, Boeijinga P, et al. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Psychopharmacology (Bed), 2005, 181: 790-798.
  • 7Hajak G. A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience. Drug Saf,1999, 21: 457-469.
  • 8Walsh JK, Mayleben D, Guico-Pabia C, et al. Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial. Sleep Med, 2008, 9: 393-402.
  • 9Deacon S, Staner L, Staner C, et al. Acute administration of gaboxadol improves sleep initiation and maintenance in patients with primary insomnia. Sleep, 2005, 28: A240.
  • 10Mathias S, Zihl J, Steiger A, et al. Effect of repeated gaboxadol administration on night sleep and next-day performance in healthy elderly subjects. Neuropsychopharmacology, 2005, 30: 833-841.

二级参考文献8

  • 1蔡焯基,汤宜朗,马辛.抑郁症基础与临床.2版.北京:科学出版社,2002:27.
  • 2Demyttenaere K, Bruffaerts R, Posada-Villa J, et al. Prevalence, severity and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA, 2004, 291: 2581-2590.
  • 3Tylee A, Gastpar M, Lepine JP, et al. DEPRES Ⅱ (Depression Research in European Society Ⅱ ): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. Int Clin Psychopharmacol, 1999, 14: 139-151.
  • 4Shen J, Chung SA, Kayumov L, et al. Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine. Can J Psychiatry, 2006, 51 : 27-34.
  • 5Schittecatte M, Dumont F, Machowski R, et al. Effects of mirtazapine on sleep polygraphic variables in major depression. Neuropsychobiology, 2002, 46 : 197-201.
  • 6America Psychiatrtric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington ( DC ) : America Psychiatrtric Association, 1994.
  • 7Holm K J, Markham A. Mirtazapine: a review of its use in major depression. Drugs, 1999, 57: 607-631.
  • 8Schmid DA, Wichniak A, Uhr M, et al. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, Prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neurepsychopharmacology, 2006, 31 : 832-844.

共引文献7

同被引文献228

引证文献27

二级引证文献2139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部